Buse, Dawn C.
Cady, Roger
Starling, Amaal J.
Buzby, Meghan
Spinale, Charlie
Steinberg, Kathy
Lenaburg, Kevin
Kymes, Steven
Funding for this research was provided by:
Lundbeck LLC, Deerfield, IL, United States
Article History
Received: 22 February 2024
Accepted: 17 June 2024
First Online: 4 July 2024
Declarations
:
: All participants in this Harris Poll survey were asked to read the Harris Poll privacy policy prior to agreeing to take the survey (<i>).</i> Only those who selected “I agree to continue” moved on to the screener section. Institutional review board approval was not conducted, as this survey was non-interventional in nature, was not intended to provide clinical data for treatment decisions, was not conducted as a clinical trial for any endpoints, and data are not identifiable in the results presented herein.
: Not applicable.
: D.C. Buse has received grant support from Amgen, the US Food and Drug Administration, and the National Headache Foundation; has served as a consultant and received honoraria from AbbVie/Allergan, Amgen/Novartis, Biohaven, Collegium, Eli Lilly, Lundbeck, and Teva; and has served on the editorial board of Current Pain and Headache Reports. R. Cady was an employee of Lundbeck LLC at the time of survey development and initiation; has served as a consultant with Biohaven, Haleon, and Lundbeck; and is a current part-time employee of Axon Therapeutics. A.J. Starling has received consulting fees from AbbVie, Allergan, Amgen, Axsome Therapeutics, Everyday Health, Lundbeck, Med-IQ, Medscape, Neurolief, Satsuma, and WebMD. M. Buzby is an employee of the Coalition for Headache and Migraine Patients, an organization that receives sponsorship support from AbbVie, Amgen, Eli Lilly, Impel, Lundbeck, and Teva. C. Spinale and K. Steinberg are employees of The Harris Poll, a company that received funding from Lundbeck LLC for conducting this research. K. Lenaburg was an employee of the Coalition for Headache and Migraine Patients (CHAMP) during the development and fielding of this survey, an organization that receives support from AbbVie, Amgen, Eli Lilly, Impel, Lundbeck, and Teva. In addition, he has received consulting fees from AbbVie, Allergan, Impel, and Lundbeck. S. Kymes was an employee of Lundbeck LLC at the time of this study.